Maxiphen DM (MCR American Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the Maxiphen DM drug offered from MCR American Pharmaceuticals, Inc.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | MCR American Pharmaceuticals, Inc. |
NON-PROPRIETARY NAME: | Guaifenesin, Phenylephrine Hydrochloride, and Dextromethorphan Hydrobromide |
SUBSTANCE NAME: | GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | OTC MONOGRAPH FINAL |
START MARKETING DATE: | 2008-03-31 |
END MARKETING DATE: | 0000-00-00 |
Maxiphen DM HUMAN OTC DRUG Details:
Item Description | Maxiphen DM from MCR American Pharmaceuticals, Inc. |
LABELER NAME: | MCR American Pharmaceuticals, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 400; 10; 20(mg/1; mg/1; mg/1) |
START MARKETING DATE: | 2008-03-31 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 58605-423_1a720629-daee-4f54-b8ed-6d0d69c9d1cd |
PRODUCT NDC: | 58605-423 |
APPLICATION NUMBER: | part341 |
Other GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE Pharmaceutical Manufacturers / Labelers: